BioMed Intelligence, Inc. Unveils RxCube – Unsurpassed Business Intelligence Technology for the Pharmacy Services Industry

TALLAHASSEE, Fla.--(BUSINESS WIRE)-- BioMed Intelligence, Inc. (BMI) today announced the launch of RxCube, BMI’s new interactive online data warehouse and reporting tool designed to provide the pharmacy services industry instantaneous data accessibility to track and analyze utilization trends, identify patient care management issues and determine cost saving opportunities. BMI’s RxCube creates the opportunity for pharmacies to effectively eliminate reporting gaps they often face in trying to support their internal and external (i.e. REMS, payer, Pharma, etc.) client data reporting requirements.

Effective pharmacy management relies on accurate and accessible information derived from integrated datasets. BMI’s RxCube puts the power of integrated data directly within a pharmacy’s control by providing flexibility to track critical statistics detailing operational, financial, and clinical performance. More importantly, using RxCube’s intuitive user interface, business managers, clinicians and other organizational disciplines can utilize these statistics to identify trends and their causes, and effectively target and investigate opportunities for improvement across their businesses. RxCube’s advanced trend indicators enable direct access to measure KPIs against budgets, previous periods, and specific financial goals.

RxCube enables pharmacies to:

  • Identify and investigate profit margin changes
  • Monitor reimbursement rates & conduct contracted rate validations
  • Track patient adherence/compliance
  • Measure clinical program outcomes
  • Evaluate staffing needs & related operational dispensing costs
  • Streamline and efficiently support contractual Pharma, Credentialing, & Data Aggregators

According to Jim Maguire, BMI’s Chief Executive Officer, “BMI’s RxCube is a cutting-edge tool and a valuable new addition to our product portfolio of robust analytical tools supporting the pharmacy services industry. BMI’s commitment to our clients is evident through our ongoing development and delivery of innovative technology solutions that enable cost reductions and increase profitability.”

About BioMed Intelligence, Inc.

BioMed Intelligence, Inc. (BMI) specializes in providing technology products and services for the healthcare community. BMI's robust suite of products supports critical operational and business intelligence needs of the pharmacy services industry. Utilizing leading edge technologies and industry experts, BMI delivers value to our clients through the implementation of streamlined processes, reduced costs and improved efficiencies.


BioMed Intelligence, Inc.
Jim Maguire, CEO, 347-847-3570
Fax: 1-888-802-1090
[email protected]

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:   Technology  Data Management  Health  Other Health  General Health



Suggested Articles

While the rush to telehealth adoption may have slowed a bit from its highs early on in the pandemic, the data show consumer interest in virtual care.

Allscripts reported third-quarter 2020 revenue was $402 million, down 9% from revenue of $444 million in the third quarter of 2019. 

Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday.